NCT07186842
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07186842
Title A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioNTech SE
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | ESP | DEU

Facility Status City State Zip Country Details
Florida Cancer Specialists RECRUITING Orlando Florida 32827 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
St. Josef-Hospital im Katholischen Klinikum Bochum RECRUITING Bochum 44791 Germany Details
Hospital San Pedro RECRUITING Logroño 26006 Spain Details
Hospital Universitario HM Sanchinarro - START Madrid CIOCC RECRUITING Madrid 28050 Spain Details
Hospital Universitario Quironsalud Madrid - NEXT Oncology RECRUITING Pozuelo de Alarcón 28223 Spain Details
Northern Centre for Cancer Research RECRUITING Newcastle upon Tyne NE7 7DN United Kingdom Details
The Royal Marsden Hospital RECRUITING Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field